Throughout the entry stage, including referral, evaluation, and the IFSP meeting, data analysis was completed to guide the subsequent data collection as well as to identify preliminary themes among the data (Bogdan and Biklen, 2003).
Data analysis was completed to prove the viability of the designed model.
Additional QC of Exome Chip data set was completed to exclude samples with poor quality genotype calls, gender errors, or unclear/unexpected sibling relationships.
Additional quality control of GWAS and Exome Chip data sets was completed to exclude samples with poor quality genotype calls, gender errors, or unclear/unexpected sibling relationships.
Some data was completed up to spring 2014 using web pages and publications and, later, interviews.
The analysis of the data was completed according to the method previously described.
Clinical data were complete to August 2012.
Overall survival data were complete to the end of 2008.
Once the coding of the data was completed, connections between codes led to the identification of analytic categories, and ultimately, to the development of an overriding explanation [ 20].
A desktop survey of climatological data was completed before the experiment, providing information to inform site selection and experiment design.
